A1cNow+

84% of Type 2's think they're doing just fine. But in reality, 67% of those patients are out of control.
if they feel nothing's wrong, they see no need to do anything differently.

Get the Flash Player to see this movie.


It's been shown that a 1% reduction in A1C lowers
risk of complications such as eye, kidney and nerve
disease by 40%





Bayer's A1CNow+ monitor provides accurate,
in-office A1c results, empowering physicians to
make
on the spot treatment decisions for their
patients with diabetes.





Getting quick, accurate A!C results just got
even easier with the new A1CNow+ Sampler.

- Only 5 UL of blood required
- Simple blood collection
- Fewer parts involved
- Easy disposal



Fast.
- In office testing. No waiting for lab results
- Results in just five minutes
- Hands-on procedure time is less than one minute
- Provides opportunity for immediate, face-to-face counseling

Easy.

- CLIA waived
- No calibration, no daily controls, no maintenance
- No refrigeration necessary if used within three months
- No capital equipment required
- Enables A1C testing in every exam room

Accurate.
- Proven lab accuracy at 99%
- NGSP certified

Clinical Accuracy

The A1CNow+ test is annually certified(7) by the National Glycohemoglobin Standardization Program (NGSP) and therefore traceable to the DCCT. Further, each lot is factory calibrated using a set of blood samples that have been quantitated by an NGSP certified laboratory using an NGSP certified method. Since in-field calibration is neither needed nor possible, the user cannot alter the accuracy of the test. Allowing for the normal variation seen with all laboratory methods, a 7 percent A1C using A1CNow+ will thus be, on average, the same as a 7 percent A1C on other instruments that are also calibrated to NGSP standards.

Advanced Technology

  • Uses micro-optical
    technology that
    provides results
    equivalent to the
    most sophisticated
    lab equipment.
  • Simultaneously
    conducts two, independent
    A1C tests
    and compares the
    results to ensure
    accuracy.
  • Utilizes both
    immunoassay and
    chemistry
    technology



A1CNow + ® Accurate Results

NGSP Certification

Bayer’s A1CNow + is annually certified by the National A1CNow+ vs. Reference Method

Glycohemoglobin Standardization Program (NGSP).


The purpose of the NGSP is to standardize glycated hemoglobin test results. Standardization allows A1C results to be comparable to those reported in the Diabetes Control and Complications Trial (DCCT) where relationships to mean blood glucose and risk for vascular complications have been established. 1

In order to achieve NGSP certification, an A1C testing method must successfully complete rigorous testing requirements annually. 1

If A1C testing methods pass rigorous accuracy testing criteria, they are awarded a ‘certificate of traceability to the DCCT reference method’. 1

A key component of the NGSP is the Reference Laboratory Network.The Network interacts with manufacturers of glycohemoglobin methods to assist them first in standardizing their methods and then in providing comparison data for certification of traceability to the DCCT.


Interpreting the Results

As you use A1CNow +, you may have questions about the level of performance to expect. The following information will help you answer those questions and interpret differences you may see between results when using A1CNow + and other A1C methods.


Total Error

Total error is a concept that combines both accuracy and precision. Total error is used by the NGSP to describe a test’s accuracy, and it is closely related to the probable error for a single laboratory result. NGSP certification is granted when 95% of the results from a testing method are within ±0.85% of the reference (true) value. 2


Difference Between Methods

There will always be differences between multiple test results due to normal variation, time between tests, and differences between methods. In fact, duplicate test results from the same patient will rarely match even when the test is performed using the same method at the same time. Within the NGSP’s “95% confidence interval of differences” of ±0.85%, differences can sometimes appear greater because one result could be slightly higher and the other could be slightly lower than the reference (true) value. 2


Sources of Variation

There are a variety of methods used to measure A1C, and all methods are susceptible to interference from variant hemoglobins, such as Hb S and Hb C. Pathologic conditions that affect red cell half-life can also affect A1C results regardless of the testing method. These conditions may include: iron deficiency anemia (prolonged red cell survival, leading to increased A1C results), chronic blood loss, or chronic renal failure (shortened red cell survival, leading to lowered A1C results).

 

Bayer A1CNow+
The first single-use, quantitative test for long-term glucose monitoring for people with diabetes. CLIA waiver is a regulatory status available only for those diagnostic technologies deemed so simple to use that the likelihood of an erroneous result is negligible, in accordance with the Clinical Laboratory Improvement Amendments (CLIA).

For medical professional use only. This product cannot be purchased for personal or home use.

**Includes 1 test meter, 20 disposable test strips and 20 easy samplers.

Same great product now with new easy sampler. Now with 20 tests per box.


**Includes 1 test meter, 20 disposable test strips and 20 easy samplers. (880-3021)

$178.50

Add to Wishlist
Quantity: